Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline vs TMP-SMX for uSSTI
NCT03637400Phase 2Completed
- Sponsor
- The Lundquist Institute
- Start
- Nov 2018
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of doxycycline in skin and soft tissue infection (SSTI) (2 arms), sponsored by The Lundquist Institute. Primary endpoint: Clinical cure at Early Clinical Response visit. Started Nov 2018; status: completed.
02
Drugs
doxycycline
03
Conditions
skin and soft tissue infection (SSTI)
Beyond the preview
Go deeper on NCT03637400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03637400.